Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment. (nature.com)

Authors: Zhavoronkov A … Gladyshev VN Journal: Nature Biotechnology Published: 2026-09-07 DOI: https://doi.org/10.1038/s41587-026-03286-y